By CHAD BRAY
In a research note on Tuesday, two BNP Paribas analysts said that a sweetened offer by Pfizer for the British drug maker of about 75 billion pounds, or about $127.7 billion, would still make “economic sense.”
Published: June 24, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1v17fEu
from WordPress http://ift.tt/1ita3KK
via Hadi Aboukhater
No comments:
Post a Comment